Based on the FDA, breakthrough therapy designation relates to a drug that “treats a serious or everyday living-threatening affliction and preliminary scientific evidence suggests the drug might display significant improvements above readily available therapy over a clinically substantial endpoint.”Psilocybin mushrooms could possibly be federall